GBT logo

GBT Cash From Financing

Annual CFF

$434.33 M
+$347.21 M+398.55%

December 31, 2021

Summary

Performance

1-Year Change

+398.55%

3-Year Change

+9.16%

5-Year Change

+84.68%

15-Year Change

+84.68%

GBT Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$434.33 M
GBT annual cash flow from financing activities is currently at an all-time high

3-Year Low

$434.33 M
GBT annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
GBT previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
GBT next annual earnings announcement has not yet been scheduled

OtherGBTcash flowmetrics:

Annual CFI

$12.11 M
GBT annual cash flow from investing activities is $12.11 million

Annual CFO

-$256.81 M
GBT annual cash flow from operations is -$256.81 million

Annual FCF

-$260.05 M
GBT annual free cash flow is -$260.05 million

Annual CAPEX

$3.23 M
GBT annual capital expenditures is $3.23 million

Quarterly CFF

$48.60 M
+$46.99 M+2933.52%

June 30, 2022

Summary

Performance

3-Month Change

+2933.52%

1-Year Change

+16542.81%

3-Year Change

-74.93%

5-Year Change

+9658.43%

GBT Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$387.17 M
GBT quarterly cash flow from financing activities is currently -87.45% below its historical high of $387.17 million

3-Year Low

$1.60 M
GBT quarterly cash flow from financing activities is currently +2933.52% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
GBT previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
GBT next earnings announcement has not yet been scheduled

OtherGBTcash flowmetrics:

Quarterly CFI

-$134.66 M
GBT quarterly cash flow from investing activities is -$134.66 million

Quarterly CFO

-$44.31 M
GBT quarterly cash flow from operations is -$44.31 million

Quarterly FCF

-$44.69 M
GBT quarterly free cash flow is -$44.69 million

Quarterly CAPEX

$384.00 K
GBT quarterly capital expenditures is $384.00 thousand

TTM CFF

$482.46 M
+$48.30 M+11.13%

June 30, 2022

Summary

Performance

3-Month Change

+11.13%

1-Year Change

+499.38%

3-Year Change

+61.81%

5-Year Change

+61.81%

GBT TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$482.46 M
GBT TTM cash flow from financing activities is currently at an all-time high

3-Year Low

$434.16 M
GBT TTM cash flow from financing activities is currently +11.13% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
GBT previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
GBT next earnings announcement has not yet been scheduled

OtherGBTcash flowmetrics:

TTM CFI

-$390.80 M
GBT TTM cash flow from investing activities is -$390.80 million

TTM CFO

-$249.40 M
GBT TTM cash flow from operations is -$249.40 million

TTM FCF

-$251.35 M
GBT TTM free cash flow is -$251.35 million

TTM CAPEX

$1.95 M
GBT TTM capital expenditures is $1.95 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

GBT Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+398.6%+10000.0%+499.4%
3 y3 years+9.2%-74.9%+61.8%
5 y5 years+84.7%+9658.4%+61.8%

GBT Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-87.4%-96.7%at high-10.0%
5 y5-yearat high-79.9%-87.4%-99.4%at high-83.3%
alltimeall timeat high-96.5%-87.4%-100.3%at high-99.0%

Global Blood Therapeutics Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2022
-
$48.60 M(+2933.5%)
$482.46 M(+11.1%)
Mar 2022
-
$1.60 M(-99.6%)
$434.16 M(-0.0%)
Dec 2021
$434.33 M(+398.5%)
$387.17 M(+758.6%)
$434.33 M(+253.1%)
Sep 2021
-
$45.09 M(>+9900.0%)
$123.00 M(+52.8%)
Jun 2021
-
$292.00 K(-83.6%)
$80.49 M(-8.6%)
Mar 2021
-
$1.78 M(-97.7%)
$88.12 M(+1.1%)
Dec 2020
$87.12 M(-70.8%)
$75.84 M(+2836.1%)
$87.12 M(-0.6%)
Sep 2020
-
$2.58 M(-67.4%)
$87.62 M(-3.3%)
Jun 2020
-
$7.91 M(+909.4%)
$90.58 M(-67.2%)
Mar 2020
-
$784.00 K(-99.0%)
$276.50 M(-7.3%)
Dec 2019
$298.16 M(-25.1%)
$76.34 M(+1276.5%)
$298.16 M(-18.1%)
Sep 2019
-
$5.55 M(-97.1%)
$364.14 M(+1.0%)
Jun 2019
-
$193.83 M(+763.5%)
$360.57 M(+114.6%)
Mar 2019
-
$22.45 M(-84.2%)
$168.00 M(-57.8%)
Dec 2018
$397.91 M
$142.33 M(+7128.3%)
$397.91 M(+12.8%)
Sep 2018
-
$1.97 M(+57.0%)
$352.74 M(+0.3%)
Jun 2018
-
$1.25 M(-99.5%)
$351.52 M(+0.2%)
DateAnnualQuarterlyTTM
Mar 2018
-
$252.36 M(+159.7%)
$350.76 M(+49.1%)
Dec 2017
$235.19 M(+99.1%)
$97.16 M(>+9900.0%)
$235.19 M(+70.3%)
Sep 2017
-
$754.00 K(+51.4%)
$138.07 M(-2.9%)
Jun 2017
-
$498.00 K(-99.6%)
$142.20 M(-44.1%)
Mar 2017
-
$136.78 M(>+9900.0%)
$254.43 M(+115.4%)
Dec 2016
$118.14 M(-7.9%)
$33.00 K(-99.3%)
$118.14 M(+0.1%)
Sep 2016
-
$4.89 M(-95.7%)
$117.98 M(-50.9%)
Jun 2016
-
$112.73 M(>+9900.0%)
$240.08 M(+86.3%)
Mar 2016
-
$494.00 K(-480.0%)
$128.85 M(+0.4%)
Dec 2015
$128.32 M(+85.2%)
-$130.00 K(-100.1%)
$128.32 M(-29.6%)
Sep 2015
-
$126.98 M(+8348.6%)
$182.33 M(+229.2%)
Jun 2015
-
$1.50 M(-3953.8%)
$55.38 M(-13.8%)
Mar 2015
-
-$39.00 K(-100.1%)
$64.23 M(-7.3%)
Dec 2014
$69.30 M(+353.5%)
$53.88 M(>+9900.0%)
$69.30 M(+349.6%)
Sep 2014
-
$34.00 K(-99.7%)
$15.41 M(+0.2%)
Jun 2014
-
$10.35 M(+105.8%)
$15.38 M(+205.8%)
Mar 2014
-
$5.03 M
$5.03 M
Dec 2013
$15.28 M
-
-

FAQ

  • What is Global Blood Therapeutics annual cash flow from financing activities?
  • What is the all time high annual CFF for Global Blood Therapeutics?
  • What is Global Blood Therapeutics annual CFF year-on-year change?
  • What is Global Blood Therapeutics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Global Blood Therapeutics?
  • What is Global Blood Therapeutics quarterly CFF year-on-year change?
  • What is Global Blood Therapeutics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Global Blood Therapeutics?
  • What is Global Blood Therapeutics TTM CFF year-on-year change?

What is Global Blood Therapeutics annual cash flow from financing activities?

The current annual CFF of GBT is $434.33 M

What is the all time high annual CFF for Global Blood Therapeutics?

Global Blood Therapeutics all-time high annual cash flow from financing activities is $434.33 M

What is Global Blood Therapeutics annual CFF year-on-year change?

Over the past year, GBT annual cash flow from financing activities has changed by +$347.21 M (+398.55%)

What is Global Blood Therapeutics quarterly cash flow from financing activities?

The current quarterly CFF of GBT is $48.60 M

What is the all time high quarterly CFF for Global Blood Therapeutics?

Global Blood Therapeutics all-time high quarterly cash flow from financing activities is $387.17 M

What is Global Blood Therapeutics quarterly CFF year-on-year change?

Over the past year, GBT quarterly cash flow from financing activities has changed by +$48.30 M (+16542.81%)

What is Global Blood Therapeutics TTM cash flow from financing activities?

The current TTM CFF of GBT is $482.46 M

What is the all time high TTM CFF for Global Blood Therapeutics?

Global Blood Therapeutics all-time high TTM cash flow from financing activities is $482.46 M

What is Global Blood Therapeutics TTM CFF year-on-year change?

Over the past year, GBT TTM cash flow from financing activities has changed by +$401.97 M (+499.38%)